Argenx SE
ARGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001697862
No open-market purchases or sales by Argenx SE insiders were filed in the last 90 days; 510 institutions reported holding it in 13F filings for Q2 2026, worth $26.1B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Argenx SE as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 290
- +18 vs. Q1 2023
- Shares held
- 30.9M
- −313.2K (−1.0%) vs. Q1 2023
- Total value
- $12.0B
- +$415.0M (+3.6%) vs. Q1 2023
- New holders
- 55
- 99 more added
- Sold out
- 37
- 83 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 510 | $26.1B |
| Q1 2026 | 478 | $21.1B |
| Q4 2025 | 510 | $25.0B |
| Q3 2025 | 470 | $22.5B |
| Q2 2025 | 439 | $17.7B |
| Q1 2025 | 448 | $19.7B |
| Q4 2024 | 397 | $21.0B |
| Q3 2024 | 358 | $19.0B |
| Q2 2024 | 336 | $14.7B |
| Q1 2024 | 328 | $13.4B |
| Q4 2023 | 346 | $12.5B |
| Q3 2023 | 341 | $15.9B |
| Q2 2023 | 290 | $12.0B |
| Q1 2023 | 272 | $11.6B |
| Q4 2022 | 271 | $11.6B |
| Q3 2022 | 255 | $11.2B |
| Q2 2022 | 232 | $12.4B |
| Q1 2022 | 199 | $10.2B |
| Q4 2021 | 208 | $10.1B |
| Q3 2021 | 182 | $8.57B |
| Q2 2021 | 177 | $8.57B |
| Q1 2021 | 191 | $7.84B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Argenx SE; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −10,750−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −7,838−100.0% | Sold out |
| Tobam | 0 | $0 | 0.00% | −7,387−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −7,239−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −6,156−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −4,607−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −4,218−100.0% | Sold out |
| Banque Pictet & Cie SA | 0 | $0 | 0.00% | −3,820−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −2,494−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −2,292−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −2,140−100.0% | Sold out |
| Capricorn Fund Managers Ltd | 0 | $0 | 0.00% | −1,723−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −1,700−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −1,578−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −1,115−100.0% | Sold out |
| Connective Portfolio Management, LLC | 0 | $0 | 0.00% | −1,015−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −936−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −624−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −195−100.0% | Sold out |
| Fortis Capital Advisors, LLC | 0 | $0 | 0.00% | −147−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Syverson Strege & Co | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Schubert & Co | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Baker Avenue Asset Management, LP | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| WR Wealth Planners, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |